Independent Director, Chief Executive Officer of Second Half Healthcare Advisors
John Bigalke has been a member of the Premier board of directors since 2019. He has served as the Chief Executive Officer of Second Half Healthcare Advisors, a healthcare strategy firm in Orlando, Florida, since founding the firm in 2016. He was previously with Deloitte USA LLP from 1998 to 2016, where he served as Vice Chairman and National Industry Leader for the Health Care and Life Science Practice from 2002 until 2012 and vice chairman and senior partner, Global Health Care Practice from 2012 to 2016.
Bigalke currently serves on the boards of directors of Progenity Inc., a NASDAQ-listed biotechnology company (chair of the Audit Committee and Special Committee and member of Nominating and Governance Committee), and AdventHealth (non-voting member of Audit Committee, Finance and Strategy Committee and Risk and Corporate Responsibility Committee). He also serves on the Advisory Board of Concord Healthcare Management Services LLC and Vaxcare Inc. (chair). He previously served on the boards of Deloitte USA LLP (chair of Audit and Finance committee and member of Executive Committee, Risk Committee and Strategy Committee) and the Healthcare Financial Management Association (Strategy Committee and Executive Committee).
Bigalke obtained a bachelor’s degree from Clemson University. He completed the Leadership Development Program at Columbia University Graduate School of Business and the Executive Leadership Program at the Wharton School of the University of Pennsylvania. Bigalke is a licensed Certified Public Accountant.